Developing non-invasive sensors to monitor autoimmune diseases like multiple sclerosis
Immulogical Niches and Non-invasive Biosensors for Autoimmune Monitoring
This study is exploring a new, gentle way to keep an eye on multiple sclerosis by using special sensors to track immune cells in your body, which could help you manage your condition better without needing painful biopsies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10953807 on NIH RePORTER |
What this research studies
This research focuses on creating a new way to monitor multiple sclerosis, an autoimmune disease that causes unpredictable relapses and remissions. By developing an immunological niche within the body, researchers aim to collect immune cells without the need for invasive biopsies. This approach uses advanced tissue engineering and non-invasive optical sensors to track disease progression and response to treatment. Patients may benefit from improved monitoring techniques that could lead to better management of their condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with multiple sclerosis who experience unpredictable disease activity.
Not a fit: Patients with other autoimmune diseases or those who do not have multiple sclerosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective monitoring and management of multiple sclerosis, potentially reducing relapse rates and improving patient outcomes.
How similar studies have performed: Previous research has shown promise in using non-invasive monitoring techniques for autoimmune diseases, suggesting that this approach could be viable.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Morris, Aaron Harvey — University of Michigan at Ann Arbor
- Study coordinator: Morris, Aaron Harvey
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.